OTUB1 mediates PARP1 deubiquitination to alleviate NAFLD by regulating HMGB1

Shuhua Ai1, Juanli Pan2, Qi Liu3

  • 1Department of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang City, 421001, Hunan province, China; Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, the Second Affiliated Hospital, University of South China, Hengyang, 421001, Hunan, China.

PubMed

Insights

Targeting OTUB1, an enzyme upregulated in nonalcoholic fatty liver disease (NAFLD), shows promise. Reducing OTUB1 improves glucose/lipid metabolism and liver health, suggesting it as a potential therapeutic target for NAFLD.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Metabolic Diseases

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic condition marked by hepatocyte steatosis.
  • OTUB1 is implicated in regulating glucose and lipid metabolism, suggesting a role in NAFLD pathogenesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which OTUB1 influences NAFLD.
  • To investigate OTUB1's regulatory role in glucose and lipid metabolism within NAFLD models.

Main Methods:

  • Established a high-fat-diet induced NAFLD mouse model.
  • Performed glucose and insulin tolerance tests, measured serum lipid profiles (TC, TG) and liver enzymes (ALT, AST, ALP).
  • Utilized molecular techniques including RT-qPCR, Western blot, immunofluorescence, and co-immunoprecipitation to assess gene expression, protein interactions, and pathological changes.

Main Results:

  • OTUB1 expression was significantly elevated in NAFLD models.
  • OTUB1 knockout ameliorated glucose intolerance, insulin resistance, reduced TG and TC levels, and decreased liver enzyme levels.
  • OTUB1 regulates PARP1 expression by inhibiting its ubiquitination; PARP1 knockout mitigated liver inflammation via HMGB1, improving NAFLD.

Conclusions:

  • OTUB1 plays a crucial role in the pathogenesis of NAFLD.
  • Modulating OTUB1 activity, particularly by inhibiting its ubiquitination of PARP1, offers a potential therapeutic strategy for NAFLD.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
807